Monday, May 16, 2016 | 9:00 AM - 5:00 PM
Speakers: Kivanc Birsoy (The Rockefeller University), Steven S. Gross (Weill Cornell Medical College), Marcia Haigis (Harvard Medical School), Kayvan R. Keshari (Memorial Sloan Kettering Cancer Center), Brendan D. Manning (Harvard T.H. Chan School of Public Health), Joshua Rabinowitz (Princeton University), David M. Sabatini (Whitehead Institute), Reuben Shaw (Salk Institute for Biological Studies), and Eileen White (Rutgers University)
This symposium will highlight insights into tumor metabolism from leaders in the field and explore how this information is being used to design safe and effective, metabolism-targeted therapies.
May 18 - 20, 2016
Keynote Speakers: Nora D. Volkow (National Institute on Drug Abuse, U.S. National Institutes of Health), George F. Koob (National Institute on Alcohol Abuse and Alcoholism, U.S. National Institutes of Health), and The Honorable Patrick J. Kennedy (Former United States Representative, Rhode Island; Co-Founder, One Mind; and Founder, Kennedy Forum)
Discover from leading experts, including NIAAA and NIDA directors, the latest on neurobiology of addiction; susceptibility of the teen brain; new treatment strategies; and social, economic, political, and legislative aspects of this disease.
Wednesday, May 18, 2016 | 5:45 PM - 7:00 PM
Moderator: Claudia Wallis (Scientific American Mind)
Panelists: Jeremy Waletzky (The George Washington University), Nora D. Volkow (NIH), and Honorable Gregory P. Canova, JD; additional panelist to be announced
1.3 million adolescents in the US have substance use disorder and marijuana use among teens now exceeds cigarette smoking. Join us for a public panel discussion on how neuroscience intersects with policy to improve lives of teens with addiction.
Wednesday, May 25, 2016 | 11:30 AM - 5:00 PM
Speakers: Philip A. Cole (Johns Hopkins University School of Medicine), Kenneth W. Duncan (Epizyme, Inc.)
The Chemical Biology Discussion Group brings together chemists and biologists interested in discussing the latest breakthroughs. In 2016, the annual year-end meeting features keynote speakers Dr Philip Cole and Dr Kenneth Duncan.
Tuesday, June 28, 2016 | 8:00 AM - 5:30 PM
Keynote Speaker: Giancarlo Comi (Universitè Vita-Salute San Raffaele)
Explore novel and emerging treatments for multiple sclerosis, including biomarkers and MRI usage in disease diagnosis, prognosis, and monitoring.
Thursday, April 28, 2016 | 9:00 AM - 5:00 PM
Keynote Speaker: Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
Speakers: Michael Elowitz (California Institute of Technology), Eric Campeau (Zenith Epigenetics), Ewelina Kulikowski (Resverlogix Corp), Keiko Ozato (National Institute of Child Health and Human Development), Roberto Pili (Indiana University School of Medicine), Patrick Trojer (Constellation), Christopher Vakoc (Cold Spring Harbor Laboratory), Daniel Vitt (4SC AG)
Epigenetic abnormalities are a recognized contributing factor in tumorigenesis and other diseases. This symposium describes recent progress in validating the therapeutic potential of small molecule inhibitors targeting epigenetics marks.
April 13 - 14, 2016
Keynote Speakers: Richard Hodes (National Institute on Aging and National Institutes of Health), Felipe Sierra (National Institute on Aging and National Institutes of Health), Steven Austad (University of Alabama at Birmingham), and Elissa Epel (University of California, San Francisco)
Explore how chronic diseases — specifically HIV/AIDS, diabetes, and cancer — can affect the seven mechanistic pillars of aging.
March 30 - April 1, 2016
Keynote Speakers: Richard Gilbertson (Cambridge Cancer Center, University of Cambridge), Craig B. Thompson (Memorial Sloan Kettering Cancer Center)
Discover the latest on pediatric cancers from leading experts, including etiological differences between pediatric and adult cancers, epigenetics, mechanisms of metastasis and disease recurrence, risk factors, diagnostics, and novel treatment approaches.
Friday, March 4, 2016 | 9:00 AM - 6:00 PM
Keynote Speakers: Sébastien Bubeck (Microsoft Research), Alex Graves (Google Research), Alexander Rakhlin (University of Pennsylvania), Ambuj Tewari (University of Michigan)
This symposium features keynote speakers in applied and theoretical machine learning as well as "spotlight" talks selected from poster abstract submissions.
Organizers: Jane S. Lebkowski (Asterias Biotherapeutics), George Zavoico (JonesTrading Institutional Services), Sonya Dougal (The New York Academy of Sciences), and Caitlin McOmish (The New York Academy of Sciences)
This eBriefing considers efforts to rethink clinical, regulatory, and manufacturing approaches to accelerate the transition of cell-based therapies to the clinic.
Edited by Daniel H. Geschwind
(University of California, Los Angeles)
Scholarly commissioned review articles on topics spanning neurology and psychiatry
Organizers: Robert Martone (St. Jude Children's Research Hospital) and Sonya Dougal (The New York Academy of Sciences)
This eBriefing explores tau-related mechanisms of neurodegeneration and emerging therapeutic strategies focused on tau.
Edited by Mone Zaidi
(Mount Sinai School of Medicine, New York, New York)
Papers in MARROW discuss basic, translational, and clinical bone and bone marrow biology and medicine.